Sunday, November 28, 2021  | 22 Rabiulakhir, 1443
Samaa TV
Facebook Twitter Youtube
HOME > Health

EU agency reviewing blood clots with Johnson & Johnson vaccine

Four cases, one fatal reported

SAMAA | - Posted: Apr 9, 2021 | Last Updated: 8 months ago
SAMAA |
Posted: Apr 9, 2021 | Last Updated: 8 months ago

Photo: AFP

Listen to the story
The EU's drug regulator said Friday it had launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after reports of four cases, one of them fatal. The European Medicines Agency (EMA) said its safety committee "has started a review of a safety signal to assess reports of thromboembolic events" with people who had received the shot. "Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with Covid-19 Vaccine Janssen," the EMA said, referring to US pharma giant J&J's European subsidiary. "One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the USA. One of them was fatal." The watchdog has approved the Johnson & Johnson vaccine for use but its rollout across the 27-nation EU is not due to start until later this month. The probe comes days after the Amsterdam-based watchdog said it was listing the same type of blood clots as a very rare side effect of the rival AstraZeneca vaccine.  Both jabs use similar adenovirus vector technology.
FaceBook WhatsApp

The EU’s drug regulator said Friday it had launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after reports of four cases, one of them fatal.

The European Medicines Agency (EMA) said its safety committee “has started a review of a safety signal to assess reports of thromboembolic events” with people who had received the shot.

“Four serious cases of unusual blood clots with low blood platelets have been reported post-vaccination with Covid-19 Vaccine Janssen,” the EMA said, referring to US pharma giant J&J’s European subsidiary.

“One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the USA. One of them was fatal.”

The watchdog has approved the Johnson & Johnson vaccine for use but its rollout across the 27-nation EU is not due to start until later this month.

The probe comes days after the Amsterdam-based watchdog said it was listing the same type of blood clots as a very rare side effect of the rival AstraZeneca vaccine. 

Both jabs use similar adenovirus vector technology.

 
HOME  
 
 
RELATED STORIES

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp
 
 
 
astrazeneca, EMA, europe medicines agency, astrazeneca vaccine,
 
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp